TT-00920 Placebo

DRUG2 trials

Sponsors

TransThera Sciences (Nanjing), Inc.

Conditions

Healthy

Phase 1

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Dose of TT-00920 in Healthy Subjects

CompletedNCT05043792

TransThera Sciences (Nanjing), Inc.Healthy

Start: 2021-08-19End: 2021-11-30Updated: 2023-11-18

A Phase 1 Study of TT-00920 in Healthy Subjects

CompletedNCT05355129

TransThera Sciences (Nanjing), Inc.Healthy

Start: 2021-11-03End: 2022-06-06Updated: 2023-02-27